novartis india appoints milan paleja as vice chairman and md
.
..
sign out.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..